📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients (2021)

First Author: Lin S

Attributed to: 'SPIICA' - the Sao Paulo-Imperial College Immune Correlates in Arbovirus Infection Network funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.11.10.21266168

Publication URI: http://dx.doi.org/10.1101/2021.11.10.21266168

Type: Preprint